Document is current

Any future updates will be listed below

Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells

Crossref DOI link: https://doi.org/10.1038/s41417-024-00787-3

Published Online: 2024-06-05

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark